Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo E Pergola

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Nephrology|September 1, 2022
Phosphate Frustration: Treatment Options to Complement Current TherapiesPablo E Pergola
Kidney International Reports|June 11, 2020
Current Management of Hyperkalemia in Patients on DialysisShweta Bansal, Pablo E Pergola
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2021
Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label ExtensionPablo E Pergola, Nelson P Kopyt
Advances in Chronic Kidney Disease|September 4, 2019
Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney DiseasePablo E Pergola, Steven Fishbane, Tomas Ganz
Nephrology (Carlton, Vic.)|March 5, 2004
High-dose iron gluconate in chronic kidney disease patientsRatna S Danda, Linda J Kirk, Pablo E Pergola
Kidney International|January 18, 2013
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseStacey Ruiz, Pablo E Pergola, Richard A Zager, et al.
Journal of the American Society of Nephrology : JASN|January 11, 2023
Authors' ReplyPablo E Pergola, David P Rosenbaum, Yang Yang, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2021
A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY)Pablo E Pergola, David P Rosenbaum, Yang Yang, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 15, 2018
Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS InhibitorsRobert A Kloner, Coleman Gross, Jinwei Yuan, et al.
Clinical Pharmacology and Therapeutics|June 26, 2024
Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney DiseasePamela Navarro-Gonzales, Tomas Ganz, Pablo E Pergola, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Nephrology|September 1, 2022
Phosphate Frustration: Treatment Options to Complement Current TherapiesPablo E Pergola
Kidney International Reports|June 11, 2020
Current Management of Hyperkalemia in Patients on DialysisShweta Bansal, Pablo E Pergola
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2021
Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label ExtensionPablo E Pergola, Nelson P Kopyt
Advances in Chronic Kidney Disease|September 4, 2019
Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney DiseasePablo E Pergola, Steven Fishbane, Tomas Ganz
Nephrology (Carlton, Vic.)|March 5, 2004
High-dose iron gluconate in chronic kidney disease patientsRatna S Danda, Linda J Kirk, Pablo E Pergola
Kidney International|January 18, 2013
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseStacey Ruiz, Pablo E Pergola, Richard A Zager, et al.
Journal of the American Society of Nephrology : JASN|January 11, 2023
Authors' ReplyPablo E Pergola, David P Rosenbaum, Yang Yang, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2021
A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY)Pablo E Pergola, David P Rosenbaum, Yang Yang, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 15, 2018
Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS InhibitorsRobert A Kloner, Coleman Gross, Jinwei Yuan, et al.
Clinical Pharmacology and Therapeutics|June 26, 2024
Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney DiseasePamela Navarro-Gonzales, Tomas Ganz, Pablo E Pergola, et al.
Pageof 9